Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo

Journal of Experimental Medicine

Volumn 213, Issue 5, 2016, Pages 809-825

  Liu, Yancheng ^a   Tan, Shumin ^a   Huang, Lu ^a   Abramovitch, Robert B ^b   Rohde, Kyle H ^c   Zimmerman, Matthew D ^d   Chen, Chao ^d   Dartois, Véronique ^d   VanderVen, Brian C ^a   Russell, David G ^a  

^a Cornell University ^*  (United States)

^b Michigan State University ^*  (United States)

^c UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^d PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ISONIAZID; RIFAMPICIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DRUG TOLERANCE; GENE; GENE EXPRESSION; HOST CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; STRESS; ANIMAL; ANTIBIOTIC RESISTANCE; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; IMMUNOLOGY; MICROBIOLOGY; TUBERCULOSIS, PULMONARY;

ANIMALS; CELL LINE; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; ISONIAZID; LUNG; MICE; MYCOBACTERIUM TUBERCULOSIS; MYELOID CELLS; RIFAMPIN; TRANSCRIPTION, GENETIC; TUBERCULOSIS, PULMONARY;

EID: 84969244646     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20151248     Document Type: Article

References (62)

1. Abramovitch, R.B., K.H. Rohde, F.F. Hsu, and D.G. Russell. 2011. aprABC: a Mycobacterium tuberculosis complex-specific locus that modulates pH-driven adaptation to the macrophage phagosome. Mol. Microbiol. 80:678-694. http://dx.doi.org/10.1111/j.1365-2958.2011.07601.x
2. Adams, K.N., K. Takaki, L.E. Connolly, H. Wiedenhoft, K. Winglee, O. Humbert, P.H. Edelstein, C.L. Cosma, and L. Ramakrishnan. 2011. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell. 145:39-53. http://dx.doi.org/10.1016/j.cell.2011.02.022
3. Aldridge, B.B., I. Keren, and S.M. Fortune. 2014. The spectrum of drug susceptibility in Mycobacteria. Microbiol. Spectr. 2:MGM2-0031-2013. http://dx.doi.org/10.1128/microbiolspec.MGM2-0031
4. Alland, D., I. Kramnik, T.R. Weisbrod, L. Otsubo, R. Cerny, L.P. Miller, W.R. Jacobs Jr., and B.R. Bloom. 1998. Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DEC AL): the effect of isoniazid on gene expression in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 95:13227-1 3232.
5. Baek, S.H., A.H. Li, and C.M. Sassetti. 2011. Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biol. 9:e1001065. http://dx.doi.org/10.1371/journal.pbio.1001065
6. Mt), a cyclic AMP receptor protein-like DNA binding protein. J. Bacteriol. 187:7795-7804. http://dx.doi.org/10.1128/JB.187.22.7795-7804.2005
7. Betts, J.C., P.T. Lukey, L.C. Robb, R.A. McAdam, and K. Duncan. 2002. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43:717-731. http://dx.doi.org/10.1046/j.1365-2958.2002.02779.x
8. Betts, J.C., A. McLaren, M.G. Lennon, F.M. Kelly, P.T. Lukey, S.J. Blakemore, and K. Duncan. 2003. Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47:2903-2913. http://dx.doi.org/10.1128/AAC.47.9.2903-2913.2003
9. Bhaskar, A., M. Chawla, M. Mehta, P. Parikh, P. Chandra, D. Bhave, D. Kumar, K.S. Carroll, and A. Singh. 2014. Reengineering redox sensitive GFP to measure mycothiol redox potential of Mycobacterium tuberculosis during infection. PLoS Pathog. 10:e1003902. http://dx.doi.org/10.1371/journal.ppat.1003902
10. Boshoff, H.I., T.G. Myers, B.R. Copp, M.R. McNeil, M.A. Wilson, and C.E. Barry III. 2004. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J. Biol. Chem. 279:40174-40184. http://dx.doi.org/10.1074/jbc.M406796200
11. Casabon, I., S.H. Zhu, H. Otani, J. Liu, W.W. Mohn, and L.D. Eltis. 2013. Regulation of the KstR2 regulon of Mycobacterium tuberculosis by a cholesterol catabolite. Mol. Microbiol. 89:1201-1212. http://dx.doi.org/10.1111/mmi.12340
12. Cunningham-Bussel, A., T. Zhang, and C.F. Nathan. 2013. Nitrite produced by Mycobacterium tuberculosis in human macrophages in physiologic oxygen impacts bacterial ATP consumption and gene expression. Proc. Natl. Acad. Sci. USA. 110:E4256-E4265. http://dx.doi.org/10.1073/pnas.1316894110
13. Deb, C., C.M. Lee, V.S. Dubey, J. Daniel, B. Abomoelak, T.D. Sirakova, S. Pawar, L. Rogers, and P.E. Kolattukudy. 2009. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS One. 4:e6077. http://dx.doi.org/10.1371/journal.pone.0006077
14. Edgar, R., M. Domrachev, and A.E. Lash. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30:207-210. http://dx.doi.org/10.1093/nar/30.1.207
15. Ehrt, S., D. Schnappinger, S. Bekiranov, J. Drenkow, S. Shi, T.R. Gingeras, T. Gaasterland, G. Schoolnik, and C. Nathan. 2001. Reprogramming of the macrophage transcriptome in response to interferon-γ and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194:1123-1140. http://dx.doi.org/10.1084/jem.194.8.1123
16. Fisher, M.A., B.B. Plikaytis, and T.M. Shinnick. 2002. Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes. J. Bacteriol. 184:4025-4032. http://dx.doi.org/10.1128/JB.184.14.4025-4032.2002
17. Gengenbacher, M., S.P. Rao, K. Pethe, and T. Dick. 2010. Nutrient-starved, nonreplicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability. Microbiology. 156:81-87. http://dx.doi.org/10.1099/mic.0.033084-0
18. Hampshire, T., S. Soneji, J. Bacon, B.W. James, J. Hinds, K. Laing, R.A. Stabler, P.D. Marsh, and P.D. Butcher. 2004. Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: a model for persistent organisms? Tuberculosis (Edinb.). 84:228-238. http://dx.doi.org/10.1016/j.tube.2003.12.010
19. He, H., R. Hovey, J. Kane, V. Singh, and T.C. Zahrt. 2006. MprAB is a stres-sresponsive two-component system that directly regulates expression of sigma factors SigB and SigE in Mycobacterium tuberculosis. J. Bacteriol. 188:2134-2143. http://dx.doi.org/10.1128/JB.188.6.2134-2143.2006
20. Helaine, S., A.M. Cheverton, K.G. Watson, L.M. Faure, S.A. Matthews, and D.W. Holden. 2014. Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science. 343:204-208. http://dx.doi.org/10.1126/science.1244705
21. Homolka, S., S. Niemann, D.G. Russell, and K.H. Rohde. 2010. Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival. PLoS Pathog. 6:e1000988. http://dx.doi.org/10.1371/journal.ppat.1000988
22. Kendall, S.L., P. Burgess, R. Balhana, M. Withers, A. Ten Bokum, J.S. Lott, C. Gao, I. Uhia-Castro, and N.G. Stoker. 2010. Cholesterol utilization in mycobacteria is controlled by two TetR-type transcriptional regulators: kstR and kstR2. Microbiology. 156:1362-1371. http://dx.doi.org/10.1099/mic.0.034538-0
23. Kumar, A., J.S. Deshane, D.K. Crossman, S. Bolisetty, B.S. Yan, I. Kramnik, A. Agarwal, and A.J. Steyn. 2008. Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon. J. Biol. Chem. 283:18032-18039. http://dx.doi.org/10.1074/jbc.M802274200
24. Lenaerts, A.J., V. Gruppo, K.S. Marietta, C.M. Johnson, D.K. Driscoll, N.M. Tompkins, J.D. Rose, R.C. Reynolds, and I.M. Orme. 2005. Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models. Antimicrob. Agents Chemother. 49:2294-2301. http://dx.doi.org/10.1128/AAC.49.6.2294-2301.2005
25. Maisonneuve, E., M. Castro-Camargo, and K. Gerdes. 2013. (p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity. Cell. 154:1140-1150. http://dx.doi.org/10.1016/j.cell.2013.07.048
26. Manganelli, R., M.I. Voskuil, G.K. Schoolnik, and I. Smith. 2001. The Mycobacterium tuberculosis ECF sigma factor sE: role in global gene expression and survival in macrophages. Mol. Microbiol. 41:423-437. http://dx.doi.org/10.1046/j.1365-2958.2001.02525.x
27. Manina, G., N. Dhar, and J.D. McKinney. 2015. Stress and host immunity amplify Mycobacterium tuberculosis phenotypic heterogeneity and induce nongrowing metabolically active forms. Cell Host Microbe. 17:32-46. http://dx.doi.org/10.1016/j.chom.2014.11.016
28. Mattila, J.T., O.O. Ojo, D. Kepka-Lenhart, S. Marino, J.H. Kim, S.Y. Eum, L.E. Via, C.E. Barry III, E. Klein, D.E. Kirschner, et al. 2013. Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms. J. Immunol. 191:773-784. http://dx.doi.org/10.4049/jimmunol.1300113
29. McCune, R.M. Jr., and R. Tompsett. 1956. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. J. Exp. Med. 104:737-762. http://dx.doi.org/10.1084/jem.104.5.737
30. McCune, R.M. Jr., W. McDermott, and R. Tompsett. 1956. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J. Exp. Med. 104:763-802. http://dx.doi.org/10.1084/jem.104.5.763
31. Nandakumar, M., C. Nathan, and K.Y. Rhee. 2014. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis. Nat. Commun. 5:4306. http://dx.doi.org/10.1038/ncomms5306
32. Nathan, C., and M.U. Shiloh. 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA. 97:8841-8848. http://dx.doi.org/10.1073/pnas.97.16.8841
33. Ohno, H., G. Zhu, V.P. Mohan, D. Chu, S. Kohno, W.R. Jacobs Jr., and J. Chan. 2003. The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis. Cell. Microbiol. 5:637-648. http://dx.doi.org/10.1046/j.1462-5822.2003.00307.x
34. Park, H.D., K.M. Guinn, M.I. Harrell, R. Liao, M.I. Voskuil, M. Tompa, G.K. Schoolnik, and D.R. Sherman. 2003. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol. Microbiol. 48:833-843. http://dx.doi.org/10.1046/j.1365-2958.2003.03474.x
35. Piccaro, G., F. Giannoni, P. Filippini, A. Mustazzolu, and L. Fattorini. 2013. Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions. Antimicrob. Agents Chemother. 57:1428-1433. http://dx.doi.org/10.1128/AAC.02154-12
36. Podinovskaia, M., W. Lee, S. Caldwell, and D.G. Russell. 2013. Infection of macrophages with Mycobacterium tuberculosis induces global modifications to phagosomal function. Cell. Microbiol. 15:843-859. http://dx.doi.org/10.1111/cmi.12092
37. Prideaux, B., L.E. Via, M.D. Zimmerman, S. Eum, J. Sarathy, P. O'Brien, C. Chen, F. Kaya, D.M. Weiner, P.Y. Chen, et al. 2015. The association between sterilizing activity and drug distribution into tuberculosis lesions. Nat. Med. 21:1223-1227. http://dx.doi.org/10.1038/nm.3937
38. Raman, S., T. Song, X. Puyang, S. Bardarov, W.R. Jacobs Jr., and R.N. Husson. 2001. The alternative sigma factor SigH regulates major components of oxidative and heat stress responses in Mycobacterium tuberculosis. J. Bacteriol. 183:6119-6125. http://dx.doi.org/10.1128/JB.183.20.6119-6125.2001
39. Rodrigue, S., J. Brodeur, P.E. Jacques, A.L. Gervais, R. Brzezinski, and L. Gaudreau. 2007. Identification of mycobacterial sigma factor binding sites by chromatin immunoprecipitation assays. J. Bacteriol. 189:1505-1513. http://dx.doi.org/10.1128/JB.01371-06
40. Rohde, K.H., R.B. Abramovitch, and D.G. Russell. 2007. Mycobacterium tuberculosis invasion of macrophages: linking bacterial gene expression to environmental cues. Cell Host Microbe. 2:352-364. http://dx.doi.org/10.1016/j.chom.2007.09.006
41. Rohde, K.H., D.F. Veiga, S. Caldwell, G. Balázsi, and D.G. Russell. 2012. Linking the transcriptional profiles and the physiological states of Mycobacterium tuberculosis during an extended intracellular infection. PLoS Pathog. 8:e1002769. http://dx.doi.org/10.1371/journal.ppat.1002769
42. Rustad, T.R., K.J. Minch, S. Ma, J.K. Winkler, S. Hobbs, M. Hickey, W. Brabant, S. Turkarslan, N.D. Price, N.S. Baliga, and D.R. Sherman. 2014. Mapping and manipulating the Mycobacterium tuberculosis transcriptome using a transcription factor overexpression-derived regulatory network. Genome Biol. 15:502. http://dx.doi.org/10.1186/s13059-014-0502-3
43. Saïd-Salim, B., S. Mostowy, A.S. Kristof, and M.A. Behr. 2006. Mutations in Mycobacterium tuberculosis Rv0444c, the gene encoding anti-SigK, explain high level expression of MPB70 and MPB83 in Mycobacterium bovis. Mol. Microbiol. 62:1251-1263. http://dx.doi.org/10.1111/j.1365-2958.2006.05455.x
44. Sala, A., P. Bordes, and P. Genevaux. 2014. Multiple toxin-antitoxin systems in Mycobacterium tuberculosis. Toxins (Basel). 6:1002-1020. http://dx.doi.org/10.3390/toxins6031002
45. Schnappinger, D., S. Ehrt, M.I. Voskuil, Y. Liu, J.A. Mangan, I.M. Monahan, G. Dolganov, B. Efron, P.D. Butcher, C. Nathan, and G.K. Schoolnik. 2003. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198:693-704. http://dx.doi.org/10.1084/jem.20030846
46. Sherman, D.R., M. Voskuil, D. Schnappinger, R. Liao, M.I. Harrell, and G.K. Schoolnik. 2001. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding a-crystallin. Proc. Natl. Acad. Sci. USA. 98:7534-7539. http://dx.doi.org/10.1073/pnas.121172498
47. Shiloh, M.U., P. Manzanillo, and J.S. Cox. 2008. Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection. Cell Host Microbe. 3:323-330. http://dx.doi.org/10.1016/j.chom.2008.03.007
48. Srivastava, S., J.D. Ernst, and L. Desvignes. 2014. Beyond macrophages: the diversity of mononuclear cells in tuberculosis. Immunol. Rev. 262:179-192. http://dx.doi.org/10.1111/imr.12217
49. Sturgill-Koszycki, S., P.H. Schlesinger, P. Chakraborty, P.L. Haddix, H.L. Collins, A.K. Fok, R.D. Allen, S.L. Gluck, J. Heuser, and D.G. Russell. 1994. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science. 263:678-681. http://dx.doi.org/10.1126/science.8303277
50. Sukumar, N., S. Tan, B.B. Aldridge, and D.G. Russell. 2014. Exploitation of Mycobacterium tuberculosis reporter strains to probe the impact of vaccination at sites of infection. PLoS Pathog. 10:e1004394. http://dx.doi.org/10.1371/journal.ppat.1004394
51. Sulochana, S., D.A. Mitchison, G. Kubendiren, P. Venkatesan, and C.N. Paramasivan. 2009. Bactericidal activity of moxifloxacin on exponential and stationary phase cultures of Mycobacterium tuberculosis. J. Chemother. 21:127-134. http://dx.doi.org/10.1179/joc.2009.21.2.127
52. Tan, S., N. Sukumar, R.B. Abramovitch, T. Parish, and D.G. Russell. 2013. Mycobacterium tuberculosis responds to chloride and pH as synergistic cues to the immune status of its host cell. PLoS Pathog. 9:e1003282. http://dx.doi.org/10.1371/journal.ppat.1003282
53. Tiwari, P., G. Arora, M. Singh, S. Kidwai, O.P. Narayan, and R. Singh. 2015. MazF ribonucleases promote Mycobacterium tuberculosis drug tolerance and virulence in guinea pigs. Nat. Commun. 6:6059. http://dx.doi.org/10.1038/ncomms7059
54. VanderVen, B.C., R.J. Fahey, W. Lee, Y. Liu, R.B. Abramovitch, C. Memmott, A.M. Crowe, L.D. Eltis, E. Perola, D.D. Deininger, et al. 2015. Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environment. PLoS Pathog. 11:e1004679. http://dx.doi.org/10.1371/journal.ppat.1004679
55. Vilchèze, C., and W.R. Jacobs Jr. 2007. The mechanism of isoniazid killing: clarity through the scope of genetics. Annu. Rev. Microbiol. 61:35-50. http://dx.doi.org/10.1146/annurev.micro.61.111606.122346
56. Voskuil, M.I., D. Schnappinger, K.C. Visconti, M.I. Harrell, G.M. Dolganov, D.R. Sherman, and G.K. Schoolnik. 2003. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198:705-713. http://dx.doi.org/10.1084/jem.20030205
57. Voskuil, M.I., I.L. Bartek, K. Visconti, and G.K. Schoolnik. 2011. The response of Mycobacterium tuberculosis to reactive oxygen and nitrogen species. Front. Microbiol. 2:105. http://dx.doi.org/10.3389/fmicb.2011.00105
58. Wallis, R.S., S. Patil, S.H. Cheon, K. Edmonds, M. Phillips, M.D. Perkins, M. Joloba, A. Namale, J.L. Johnson, L. Teixeira, et al. 1999. Drug tolerance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43:2600-2606.
59. Wallis, R.S., W. Jakubiec, M. Mitton-Fry, L. Ladutko, S. Campbell, D. Paige, A. Silvia, and P.F. Miller. 2012. Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide. PLoS One. 7:e30479. http://dx.doi.org/10.1371/journal.pone.0030479
60. Warner, D.F., and V. Mizrahi. 2006. Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy. Clin. Microbiol. Rev. 19:558-570. http://dx.doi.org/10.1128/CMR.00060-05
61. Wilson, M., J. DeRisi, H.H. Kristensen, P. Imboden, S. Rane, P.O. Brown, and G.K. Schoolnik. 1999. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc. Natl. Acad. Sci. USA. 96:12833-12838. http://dx.doi.org/10.1073/pnas.96.22.12833
62. Winslow, A.R., C.W. Chen, S. Corrochano, A. Acevedo-Arozena, D.E. Gordon, A.A. Peden, M. Lichtenberg, F.M. Menzies, B. Ravikumar, S. Imarisio, et al. 2010. a-Synuclein impairs macroautophagy: implications for Parkinson's disease. J. Cell Biol. 190:1023-1037. http://dx.doi.org/10.1083/jcb.201003122